Essex Investment Management’s VivoSim Labs VIVS Stock Holding History

Essex Investment Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,508	Closed	-$470K	–	479
2019 Q4	$470K	Buy	+5,508	New	+$516K	0.06%	313
2017 Q4	–	Sell	-1,912	Closed	-$1.02M	–	391
2017 Q3	$1.02M	Buy	1,912 +411	+27%	+$219K	0.14%	208
2017 Q2	$948K	Buy	1,501 +222	+17%	+$149K	0.14%	201
2017 Q1	$976K	Buy	1,279 +210	+20%	+$166K	0.15%	191
2016 Q4	$870K	Buy	+1,069	New	+$848K	0.14%	178
2014 Q1	–	Sell	-353	Closed	-$937K	–	377
2013 Q4	$937K	Buy	+353	New	+$693K	0.13%	201

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Essex Investment Management's VIVS Position: Q1 2020 in Review

Essex Investment Management sold out of VivoSim Labs (VIVS) in Q1 2020, closing a stake of 5,508 shares — an estimated $470K sold.

Essex Investment Management first reported a position in VIVS in Q4 2013 and held it in 6 quarters. The position peaked at $1.02M in Q3 2017. 75 funds tracked by Wall St. Rank hold VIVS as of Q1 2020.

Essex Investment Management reported no remaining VivoSim Labs position as of Q1 2020 after selling out during the quarter.
Essex Investment Management sold 5,508 VivoSim Labs shares in Q1 2020, an estimated $470K.
Essex Investment Management first reported a position in VivoSim Labs in Q4 2013 and held it in 6 quarters.
Essex Investment Management's VivoSim Labs position peaked at $1.02M in Q3 2017.
75 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2020.

Based on Essex Investment Management's 13F filing for Q1 2020, filed 4 May 2020.